来自患者的有机物促进非小细胞肺癌的个性化医疗:两个病例报告
Lili Qin1, Shasha Wang1, Liping Li1
1Department of Thoracic Oncology & Oncology Immunotherapy, Beijing GoBroad Hospital, Beijing, China.
Frontiers in oncology
|October 20, 2025
概括
患者衍生器官 (PDO) 引导肺癌脑转移的治疗. 这种个性化的方法在控制疾病和改善非小细胞肺癌 (NSCLC) 大脑转移患者的治疗结果方面表现有希望.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 个性化医疗是个性化的医疗.
背景情况:
- 在非小细胞肺癌 (NSCLC) 中的大脑转移导致预后不佳.
- 迫切需要有效的治疗策略.
- 患者衍生器官 (PDO) 是一种有前途的药物敏感性测试方法.
研究的目的:
- 评估基于PDO的药物敏感性查在指导NSCLC大脑转移的治疗中的有用性.
- 报告两起PDO指导疗法实现疾病控制的病例.
主要方法:
- 从NSCLC大脑转移中建立了PDO模型.
- 在PDO进行药物敏感性选.
- 根据PDO药物敏感性概况指导患者治疗.
- 监测患者对向治疗的反应.
主要成果:
- 病例1:EGFR外基因19缺失NSCLC患者对Pemetrexed,卡博普拉丁和Osimertinib组合疗法的部分反应,以PDO敏感性为指导.
- 案例2:ALK融合NSCLC患者在其他疗法进展后,根据PDO敏感性实现了对布里加替尼的部分反应.
- 这两种病例都通过PDO指导治疗证明了疾病的控制.
结论:
- PDO可以帮助优化肺癌脑转移的治疗方案.
- 以PDO为指导的治疗可以实现个性化的治疗策略.
- 这种方法可能会改善脑转移NSCLC患者的生存结果.
相关概念视频
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...


